Kevin Church

CIK: 0001822499

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (25.0%)

Position reduction

Option Exercises (M)4 (20.0%)

Derivative conversions

Awards (A)11 (55.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LONA

LeonaBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

LONA
LeonaBio, Inc.
Apr 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
300K shares-
LONA
LeonaBio, Inc.
Mar 4, 2026
Sale(S)
Direct
1.4K shares at avg. $5.37$7K
LONA
LeonaBio, Inc.
Mar 3, 2026
Exercise(M)
Direct
5.9K shares-
ATHA
Athira Pharma, Inc.
Jan 2, 2026
Sale(S)
Direct
876 shares at avg. $6.88$6K
ATHA
Athira Pharma, Inc.
Dec 31, 2025
Exercise(M)
Direct
3.7K shares-
ATHA
Athira Pharma, Inc.
Dec 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
35.1K shares-
ATHA
Athira Pharma, Inc.
Nov 18, 2025
Award(A)
Direct
1K shares at avg. $2.31$2K
ATHA
Athira Pharma, Inc.
Jul 1, 2025
Sale(S)
Direct
8.5K shares at avg. $0.29$3K
ATHA
Athira Pharma, Inc.
Jun 30, 2025
Exercise(M)
Direct
36.7K shares-
ATHA
Athira Pharma, Inc.
May 19, 2025
Award(A)
Direct
10K shares at avg. $0.23$2K
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
87.8K shares-
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Restricted Stock Units
Direct
58.6K shares-
ATHA
Athira Pharma, Inc.
Jan 2, 2025
Sale(S)
Direct
8.5K shares at avg. $0.56$5K
ATHA
Athira Pharma, Inc.
Dec 31, 2024
Exercise(M)
Direct
36.7K shares-
ATHA
Athira Pharma, Inc.
Nov 18, 2024
Award(A)
Direct
9.9K shares at avg. $0.55$5K
ATHA
Athira Pharma, Inc.
Oct 1, 2024
Award(A)
Restricted Stock Units
Direct
110K shares-
ATHA
Athira Pharma, Inc.
Oct 1, 2024
Award(A)
Stock Option (Right to Buy)
Direct
110K shares-
ATHA
Athira Pharma, Inc.
Sep 5, 2024
Sale(S)
Direct
2.5K shares at avg. $0.57$1K
ATHA
Athira Pharma, Inc.
Sep 3, 2024
Award(A)
Direct
10K shares-
ATHA
Athira Pharma, Inc.
May 20, 2024
Award(A)
Direct
5K shares at avg. $1.34$7K

		Type	Shares	Price		Ownership
Apr 9, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	300,000	-	-	Direct
Mar 4, 2026	LONA LeonaBio, Inc.	Sale(S)	1,359	$5.37	$7,298	Direct
Mar 3, 2026	LONA LeonaBio, Inc.	Exercise(M)	5,856	-	$0	Direct
Jan 2, 2026	ATHA Athira Pharma, Inc.	Sale(S)	876	$6.88	$6,027	Direct
Dec 31, 2025	ATHA Athira Pharma, Inc.	Exercise(M)	3,667	-	$0	Direct
Dec 24, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	35,138	-	-	Direct
Nov 18, 2025	ATHA Athira Pharma, Inc.	Award(A)	1,000	$2.31	$2,310	Direct
Jul 1, 2025	ATHA Athira Pharma, Inc.	Sale(S)	8,526	$0.29	$2,502	Direct
Jun 30, 2025	ATHA Athira Pharma, Inc.	Exercise(M)	36,666	-	-	Direct
May 19, 2025	ATHA Athira Pharma, Inc.	Award(A)	10,000	$0.23	$2,312	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	87,845	-	-	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Restricted Stock Units	58,563	-	-	Direct
Jan 2, 2025	ATHA Athira Pharma, Inc.	Sale(S)	8,510	$0.56	$4,782	Direct
Dec 31, 2024	ATHA Athira Pharma, Inc.	Exercise(M)	36,667	-	$0	Direct
Nov 18, 2024	ATHA Athira Pharma, Inc.	Award(A)	9,920	$0.55	$5,456	Direct
Oct 1, 2024	ATHA Athira Pharma, Inc.	Award(A) Restricted Stock Units	110,000	-	-	Direct
Oct 1, 2024	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	110,000	-	-	Direct
Sep 5, 2024	ATHA Athira Pharma, Inc.	Sale(S)	2,525	$0.57	$1,429	Direct
Sep 3, 2024	ATHA Athira Pharma, Inc.	Award(A)	10,000	-	$0	Direct
May 20, 2024	ATHA Athira Pharma, Inc.	Award(A)	4,953	$1.34	$6,637	Direct

1-20 of 20 transactions

About CHURCH KEVIN

CHURCH KEVIN (SEC CIK 0001822499) files insider reports with the SEC as CHIEF SCIENTIFIC OFFICER of LeonaBio, Inc. (LONA).

Signal8 holds 9 ownership filings by CHURCH KEVIN, all Form 4s, filed between Sep 5, 2024 and Apr 13, 2026. Those filings report 20 transactions, from May 20, 2024 to Apr 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on CHURCH KEVIN's filings is in BOTHELL, WA.

Recent filings by CHURCH KEVIN

Apr 9, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Mar 4, 2026: Open-market sale of LONA shares (Form 4, code S).
Mar 3, 2026: Option exercise of LONA shares (Form 4, code M).
Jan 2, 2026: Open-market sale of ATHA shares (Form 4, code S).
Dec 31, 2025: Option exercise of ATHA shares (Form 4, code M).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes